Antiphospholipid syndrome (APS) is classified as the association of thrombotic events
and/or obstetric morbidity in patients persistently positive for antiphospholipid antibodies …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by clinical
manifestations such as thrombosis and obstetric complications with documented persistence …

Antiphospholipid syndrome (APS) is an autoimmune disease manifested by a thrombotic or
obstetrical event in the presence of antiphospholipid antibodies. Obstetrical APS was initially …

The use of low-dose aspirin and heparinoids has improved the pregnancy outcome in
obstetric antiphospholipid syndrome (APS). However, current treatment fails in 20–30% of …

Antiphospholipid syndrome, a condition characterized by one or more thrombotic or
pregnancy-related clinical features in association with medium to high levels of …

Women with antiphospholipid antibodies (aPL) are at risk of adverse pregnancy outcomes,
including recurrent first-trimester pregnancy loss and late pregnancy complications such as …

Antiphospholipid syndrome (APS) is an acquired thrombophilia with clinical manifestations
associated with the presence of antiphospholipid antibodies (aPL) in patient plasma …

Antiphospholipid syndrome is a heterogenous disorder with many pregnancy-related
complications. Despite the refinement of laboratory testing and classification criteria …

Background The optimal treatment of women with primary antiphospholipid syndrome (APS)
is still debated. About 20–30% of women with APS remain unable to give birth to healthy …

Antiphospholipid syndrome (APS) is a rare condition clinically characterized by thrombotic
events or pregnancy complications and confirmed by one or more repeatedly positive …